EPA-1722 – A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

✍ Scribed by Tandon, R.; Loebel, A.; Phillips, D.; Pikalov, A.; Hernandez, D.; Mao, Y.; Cucchiaro, J.

• Book ID: 125818141
• Publisher: Elsevier Science
• Year: 2014
• Tongue: French
• Weight: 72 KB
• Volume: 29
• Category: Article
• ISSN: 0924-9338
• DOI: 10.1016/S0924-9338(14)78861-3